SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs

Mostrar otras versiones (1)

The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are infected. However, global testing rates are falling as we emerge from the acute health emergency and remain low in many low- and middle-income countries (mean = 27 tests per 100,000 people per day). We simulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Alvin X., Toporowski, Amy, Sacks, Jilian A., Perkins, Mark D., Briand, Sylvie, van Kerkhove, Maria, Hannay, Emma, Carmona, Sergio, Rodriguez, Bill, Parker, Edyth, Nichols, Brooke E., Russell, Colin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839449/
https://www.ncbi.nlm.nih.gov/pubmed/36624344
http://dx.doi.org/10.1038/s41588-022-01267-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839449/
https://www.ncbi.nlm.nih.gov/pubmed/36624344
http://dx.doi.org/10.1038/s41588-022-01267-w

Ejemplares similares